| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce7bfa46809315703bafbf3a4283168e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d190ff62e7e6bdccf09ebe38a6d85c2f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2005-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bf26c9d9351518c66410f25971bfd3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8454a902b5d525f38dd7aff90839c7f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_392af67cb7828fa1040a15d5ba223ff0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef79155b0610ef0b3beda3d787ccfe5 |
| publicationDate |
2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2534288-T3 |
| titleOfInvention |
Therapeutic compositions against cancer that target 4Ig-B7-H3 |
| abstract |
An antibody that specifically binds to a 4Ig-B7-H3 polypeptide for use in the treatment of a patient with a tumor, in which the antibody is capable of inducing lysis of a tumor cell to which the tumor binds. antibody, and said antibody comprises one or more modifications in the Fc region that increase the affinity of the antibody towards an activating FcγR with respect to the antibody comprising a wild-type Fc region. |
| priorityDate |
2004-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |